ZC3H13 and liver cancer: Wang et al. found in the study of liver cancer that the m6A modification induced by methyltransferase ZC3H13 can reduce the stability of PKM2 mRNA, inhibit the glycolysis of liver cancer cells and reduce the degree of malignancy, and also make liver cancer more sensitive to cisplatin treatment [164].